VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SKYE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SKYESkye Bioscience, Inc.
$0.70$25M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSKYEQuarterly Financials

Skye Bioscience, Inc. (SKYE) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Skye Bioscience, Inc. (SKYE) quarterly income statement — complete revenue, gross profit & net income history

SKYE Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold172.89K0000000000000000000
COGS % of Revenue--------------------
Gross Profit-172.89K0000000000000000000
Gross Margin %--------------------
Gross Profit Growth %-----------------100%--
Operating Expenses12.5M14.9M13.26M18.24M11.76M10.67M4.97M8.41M6.15M4.09M24.71M2.84M3.1M9.28M2.92M3.22M2.89M2.46M1.82M1.83M
OpEx % of Revenue--------------------
Selling, General & Admin4.74M3.43M3.91M3.91M4.56M4.55M4.64M4.33M4.21M2.49M2.24M1.21M1.92M1.54M1.14M1.79M1.62M1.35M1.49M949K
SG&A % of Revenue--------------------
Research & Development7.76M11.47M9.36M14.34M7.2M7.79M4.88M4.08M1.95M1.59M1.25M1.79M1.18M1.54M1.78M1.43M1.27M1.11M327.73K880.67K
R&D % of Revenue--------------------
Other Operating Expenses00000-1000K-1000K0001000K-151.84K01000K000000
Operating Income-12.67M-14.9M-13.26M-18.24M-11.76M-10.67M-4.97M-8.41M-6.15M-4.09M-24.71M-2.84M-3.1M-9.28M-2.92M-3.22M-2.89M-2.46M-1.82M-1.83M
Operating Margin %--------------------
Operating Income Growth %-7.78%-39.65%-166.96%-117.05%-91.14%-161.02%79.89%-195.66%-98.45%55.98%-745.43%11.66%-7.35%-277.1%-60.64%-75.9%-66.24%-86.64%-18.26%-49.89%
EBITDA-12.5M-14.72M-13.09M-18.06M-11.58M-10.49M-4.9M-8.38M-6.12M-4.06M-24.68M-2.81M-3.07M-9.25M-2.89M-3.19M-2.86M-2.44M-1.81M-1.83M
EBITDA Margin %--------------------
EBITDA Growth %-7.94%-40.27%-166.9%-115.58%-89.11%-158.53%80.13%-198.17%-99.7%56.14%-752.85%11.96%-7.2%-279.64%-59.72%-74.48%-64.78%-84.88%-17.8%-49.85%
D&A (Non-Cash Add-back)172.89K180.01K178.9K187.07K177.38K175.29K66K29.79K27.56K28.37K28.79K33.92K33.17K31.53K28.8K27.68K26.98K24.72K7.46K1.01K
EBIT-12.67M-14.44M-12.75M-17.62M-11.1M-9.79M-3.61M-7.44M-4.58M-4.09M-24.65M-2.92M-5.15M-9.84M-2.92M-3.21M-2.84M-2.46M-1.63M-1.83M
Net Interest Income167.42K274.1K0533.09K617.6K732.27K1M511.19K-10.42K-379.83K-254.75K-177.83K6.12K-150.79K-211.23K-205.3K-199.03K-198.83K-195.36K-190.06K
Interest Income169.62K274.1K0533.09K619.05K732.27K1.29M961.24K426.51K50.3K16.56K8.6K24.51K19.01K000300
Interest Expense2.2K0001.45K-291.07K450.05K436.94K430.13K271.31K186.43K18.4K169.8K211.23K205.3K199.03K198.84K195.36K190.06K
Other Income/Expense165K453.58K509.87K622.45K658.24K919.62K1.07M510.83K1.13M-333.67K-240.07K-264.9K-2.07M-606.97K-205K-195.78K-155.38K-50.65K-5.71K-192.75K
Pretax Income-12.51M-14.44M-12.75M-17.62M-11.1M-9.75M-3.9M-7.89M-5.02M-4.42M-24.95M-3.11M-5.17M-9.89M-3.13M-3.41M-3.04M-2.51M-1.82M-2.02M
Pretax Margin %--------------------
Income Tax0003.4K2K008.07K2K003.6K01.6K05.14K050001.6K
Effective Tax Rate %0%0%0%-0.02%-0.02%0%0%-0.1%-0.04%0%0%-0.12%0%-0.02%0%-0.15%0%-0.02%0%-0.08%
Net Income-12.51M-14.44M-12.75M-17.62M-11.1M-9.75M-3.9M-7.9M-5.02M-4.42M-24.95M-3.11M-5.17M-9.89M-3.13M-3.42M-3.04M-2.51M-1.82M-2.02M
Net Margin %--------------------
Net Income Growth %-12.66%-48.18%-227.19%-123.02%-121.2%-120.51%84.37%-153.99%2.86%55.32%-697.68%9%-69.79%-293.65%-71.38%-68.93%-40.86%-67.29%-40.73%-42.51%
Net Income (Continuing)-12.51M-14.44M-12.75M-17.62M-11.1M-9.75M-3.9M-7.9M-5.02M-4.42M-24.95M-3.11M-5.17M-9.89M-3.13M-3.42M-3.04M-2.51M-1.82M-2.02M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.32-0.36-0.32-0.44-0.28-0.24-0.10-0.20-0.18-0.36-3.17-0.80-1.37-4.99-1.58-2.50-2.50-1.52-1.10-2.50
EPS Growth %-14.29%-50%-220%-120%-55.56%33.33%96.85%75%86.86%92.79%-100.63%68%45.2%-228.29%-43.64%0%0%-15.15%12.7%0%
EPS (Basic)-0.32-0.36-0.32-0.44-0.28-0.24-0.10-0.20-0.18-0.36-3.17-0.80-1.37-4.99-1.58-2.50-2.50-1.53-1.10-2.50
Diluted Shares Outstanding39.68M39.66M39.67M39.66M39.65M39.97M38.82M38.67M28M12.35M7.88M3.89M3.77M2.51M1.98M1.98M1.98M1.66M1.66M1.51M
Basic Shares Outstanding39.68M39.66M39.67M39.66M39.65M39.97M38.82M38.67M28M12.35M7.88M3.89M3.77M2.51M1.98M1.98M1.98M1.64M1.65M1.51M
Dividend Payout Ratio--------------------